// App-Quantinova.ai

e15611 : Outcomes associated with sunitinib alternative schedule compared to traditional schedule: a single-center experience.

Researchers

Presenter

  • Bradley J. Atkinson

Principal Investigators

  • Sarathi Kalra

  • Xuemei Wang

  • Tharakeswara Bathala

  • John Perpich

  • Paul Gettys Corn

  • Nizar M. Tannir

  • Eric Jonasch

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Sunitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved